XML 17 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Revenue:      
Sale of products, net $ 16,600,244 $ 12,279,979 $ 8,521,998
Cost of goods sold (exclusive of depreciation shown separately below):      
Products 17,308,156 12,709,678 9,102,560
Gross loss (707,912) (429,699) (580,562)
Operating expenses:      
Research and development (including equity based compensation) 3,366,468 2,340,958 1,571,365
General and administrative (including equity based compensation) 7,116,535 6,193,269 7,760,127
Sales and marketing (including equity based compensation) 1,161,952 1,581,741 1,357,518
Depreciation 353,435 326,124 319,699
Amortization 593,562 516,056 454,612
Total operating expenses 12,591,952 10,958,148 11,463,321
Operating loss (13,299,864) (11,387,847) (12,043,883)
Other income (expense):      
Warrant liability (loss) gain - net (157,809) 29,615 144,550
Settlement Proceeds 0 0 1,000,000
Loss on the disposition of machinery and equipment 0 0 (15,130)
Gain (loss) on investment 346,180 (202,338) (95,684)
Unrealized loss on short-term investment securities (3,618) 0 0
Interest income 115,098 16,885 31,198
Interest expense (29,104) (37,745) (52,982)
Total other income (expense) 270,747 (193,583) 1,011,952
Loss before income taxes (13,029,117) (11,581,430) (11,031,931)
Income taxes 0 0 0
Net loss $ (13,029,117) $ (11,581,430) $ (11,031,931)
Loss per common share - basic and diluted (in dollars per share) $ (0.13) $ (0.15) $ (0.16)
Common shares used in basic and diluted earnings per share calculation (in shares) 101,161,380 79,842,773 68,143,284